ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1458	National Cancer Institute	Html	en	Cigarette Smoking: Health Risks and How to Quit (PDQ®)–Patient Version	Expert-reviewed information summary about research and guidelines focused on the prevention and cessation of cigarette smoking.	cancer treatment 0.511187 cancer prevention trials 0.526349 prevention clinical trials 0.527895 protective factors 0.503231 new cancers 0.484789 nicotine withdrawal symptoms 0.507568 PDQ cancer information 0.671083 lung cancer 0.635933 Lung Health Study 0.490849 clinical trials 0.665449 cancer information summary 0.600276 health care professionals 0.488661 clinical trial 0.538396 breast cancer prevention 0.507807 PDQ summaries 0.484382 Childhood cancer survivors 0.595809 smoking reduction 0.509721 cancer risk factor 0.545024 NCI’s PDQ 0.484019 NCI PDQ cancer 0.553403 health problems 0.510567 cancer recurrence 0.485421 nicotine replacement products 0.747838 nicotine replacement product 0.508467	Cancer prevention 0.618116 cancer protective factor 0.526183 smokers 0.498248 Cancer Information Service 0.517443 smoking 0.827105 Prevention Editorial Board 0.530978 treatment clinical trials 0.488401 National Cancer Institute 0.611044 cancer death 0.488965 health care 0.546707 new treatment 0.493726 PDQ Cigarette Smoking 0.572693 Cancer Care page 0.508742 PDQ database 0.482266 health 0.549208 childhood cancer survivor 0.513387 people 0.5314 PDQ summary 0.514038 nicotine gum 0.499264 cancer clinical trials 0.526839 risk factors 0.570886 Public Health Service 0.486542 cancer information summaries 0.523287 comprehensive cancer information 0.523579	CLICK HERE
1468	National Cancer Institute	Html	null	Testicular Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of testicular cancer.			CLICK HERE
1555	National Cancer Institute	Html	en	Chronic Myelogenous Leukemia Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of chronic myelogenous leukemia.	red blood cells 0.704307 cancer treatment 0.518767 blast cells 0.52224 blast cells increases 0.484236 following PDQ summaries 0.473092 PDQ cancer information 0.548139 clinical trial search 0.530856 bone marrow disease 0.473382 white blood cells 0.672062 donor stem cell 0.54478 clinical trials 0.856546 mature blood cells 0.534844 cancer information summary 0.513437 clinical trial 0.70787 stem cell transplant 0.622548 patients 0.481704 blood cells 0.749352 chronic myelogenous leukemia 0.997869 immature cells 0.473394 treatment clinical trial 0.482118 NCI PDQ cancer 0.480305 Treatment Editorial Board 0.48584 tyrosine kinase inhibitor 0.593512 treatment 0.640788 myeloid stem cell 0.492405	stored stem cells 0.491127 immature blood cells 0.498369 blood stem cell 0.484429 tyrosine kinase 0.602514 NCI-supported cancer 0.478389 cancer cells 0.519678 lymphoid stem cell 0.493179 specific cancer cells 0.502587 tyrosine kinase inhibitors 0.484134 stem cell 0.637917 treatment clinical trials 0.506841 blood stem cells 0.543194 National Cancer Institute 0.512761 healthy white blood 0.495783 new treatment 0.554317 white blood cell 0.525778 chronic granulocytic leukemia 0.476374 bone marrow 0.760079 blastic phase 0.485946 cancer clinical trials 0.539698 cancer 0.652333 information 0.55566 Myelogenous Leukemia Treatment 0.486009 standard treatment 0.485468	CLICK HERE
1675	National Cancer Institute	Html	en	Lymphedema (PDQ®)–Health Professional Version	Expert-reviewed information summary about the anatomy, pathophysiology, clinical manifestations, diagnosis, and treatment of cancer-related lymphedema, a condition in which lymph fluid builds up in tissues and causes swelling.	upper-limb lymphedema 0.596897 Manual lymphatic therapy 0.494091 axillary node dissection 0.485114 lymph nodes. 0.472628 upper-extremity lymphedema 0.68666 arm lymphedema 0.638618 lower-limb lymphedema 0.630542 lymph node dissection 0.832229 lower-extremity lymphedema 0.630897 deep lymphatic systems 0.498654 intestinal lymphatic trunk 0.501781 new lymphedema 0.619269 lumbar lymphatic trunk 0.502509 upper extremity lymphedema 0.623186 manual lymphatic drainage 0.477215 lymph collector vessels 0.497637 lymphatic vessels 0.762836 lymphedema onset 0.622585 secondary lymphedema 0.644407 certified lymphedema 0.696216 left subclavian vein 0.475686 lymphedema manifest 0.633761 lymphedema classification 0.594846 protein-rich lymph fluid 0.533977	secondary lymphatic vessels 0.59679 subclavian lymphatic trunk 0.576658 primary lymphatic vessels 0.596665 subcutaneous lymphatic vessels 0.50703 lymphedema 0.987634 breast cancer patients 0.473019 certified lymphedema therapist 0.652056 patients 0.478875 cancer patients 0.474035 Lymph channels 0.46738 lymph node biopsy 0.634545 breast cancer 0.848001 sentinel lymph node 0.728941 certified lymphedema therapists 0.649954 unidirectional lymphatic flow 0.496065 breast cancer survivors 0.505056 axillary lymph node 0.799687 lymph nodes 0.59192 treatable lymphedema 0.590609 lymph node biopsy. 0.539242 manual lymphedema therapy. 0.64813 lymph node drainage 0.539621 manual lymphedema therapy 0.852751	CLICK HERE
1676	National Cancer Institute	Html	en	Langerhans Cell Histiocytosis Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood Langerhans Cell Histiocytosis.	LCH lesions. 0.60623 skin lch 0.608961 high-risk LCH cases 0.650922 LCH lesions 0.663265 single-system LCH 0.624334 children 0.471295 pediatric LCH 0.607323 LCH cells 0.745404 myeloid dendritic cell 0.510622 diabetes insipidus 0.672442 Langerhans cell histiocytosis 0.581215 patients 0.683188 LCH cases 0.700352 active LCH 0.597856 multisystem involvement 0.464638 multisystem LCH 0.682353 BRAF V600E mutation 0.597618 LCH 0.901252 skin-only lch 0.612216 low-risk multisystem patients 0.491439 lung LCH cases 0.608969 high-risk multisystem disease 0.475673 myeloid dendritic cells 0.467176 aggressive LCH 0.578735 high-risk patients 0.467752	multisystem low-risk LCH 0.641412 involvement 0.465609 adult patients 0.4596 adult lung LCH 0.600979 multiorgan LCH resistant 0.594436 central diabetes insipidus 0.487545 initial LCH diagnosis 0.610781 multisystem disease 0.512583 Peribiliary LCH cells 0.620201 disease 0.533739 LCH biopsy specimens 0.639356 hepatic LCH present 0.615144 pulmonary LCH cases 0.613089 LCH cells results 0.654905 LCH patients 0.65009 LCH results 0.628645 childhood LCH 0.575582 bone marrow 0.506353 diabetes insipidus patients 0.500508 diabetes insipidus onset 0.465094 diabetes insipidus development 0.465011 term LCH cells 0.651456 pulmonary lch 0.712872 low-risk multisystem disease 0.474286	CLICK HERE
1721	National Cancer Institute	Html	en	Cruciferous Vegetables and Cancer Prevention	A fact sheet that summarizes the results of studies about cruciferous vegetables and cancer. Includes a list of cruciferous vegetables and dietary recommendations.	Netherlands—the Netherlands Cohort 0.505069 vegetable consumption 0.464589 cruciferous vegetables 0.977553 additional cohort study 0.516082 lung cancer 0.572949 anticancer effects 0.474858 colorectal cancer risk 0.625293 U.S. analysis—using data 0.461382 Breast Cancer Detection 0.503706 case-control studies 0.513186 prostate cancer risk 0.623248 lower risk 0.488713 glutathione S-transferase M1 0.504449 American Journal 0.4921 cruciferous vegetable intakes 0.595836 dark-green vegetables 0.522884 cancer chemopreventive actions 0.501377 cruciferous vegetable intake 0.689816 Cancer Epidemiology 0.57031 cohort studies 0.539353 glutathione S-transferase polymorphisms 0.4667 European Prospective Investigation 0.461912 cohort study 0.686602 cancer prevention 0.479265 United States 0.545427	Different vegetables 0.524746 multiethnic case-control study 0.487149 National Cancer Institute 0.594926 Project follow-up cohort 0.488384 Multiethnic Cohort Study 0.506189 good fiber source 0.467963 cancer researchers 0.489622 prospective cohort study 0.510047 breast cancer risk 0.615894 fruit consumption 0.483024 Clinical Nutrition 0.460261 breast cancer 0.641649 colon cancer risk 0.523965 biologically active compounds 0.464394 Goldbohm RA 0.48606 lung cancer risk 0.545247 C. Brassica vegetables 0.534883 prospective study 0.585742 glutathione S-transferase 0.517935 lung cancer mortality 0.501562 et al 0.817121 cancer risk 0.800364 Netherlands Cohort Study 0.590813 lower lung cancer 0.502455	CLICK HERE
1771	National Cancer Institute	Html	es	Sofocos y sudores nocturnos (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las causas y el tratamiento de los sofocos y sudores nocturnos en los pacientes de cáncer.	cancer treatment 0.37896 Treatment Group Trial 0.316121 ncctg trial 0.313822 Treatment Group hot 0.319139 menopausal hot 0.328045 Loprinzi CL 0.615617 trial with 0.311 menopausal symptoms 0.33934 Sin embargo 0.333136 Barton DL 0.356229 with early stage 0.313223 black cohosh 0.329892 Sloan JA 0.313934 ameliorating tamoxifen-induced hot 0.310913 randomized trial 0.317475 with hot 0.314342 phase iii 0.323066 active nonhormonal hot 0.311258 symptoms after breast 0.31045 Natl Cancer Inst 0.330125 during menopausal hot 0.313013 North Central Cancer 0.333247 tamoxifen-induced hot 0.32746 Women's Health Initiative 0.336331 Cancer Ther 0.316362	breast carcinoma 0.310376 Support Oncol 0.317335 randomized controlled 0.353057 Initiative Randomized Trial 0.310959 Cognitive behavioural treatment 0.310884 hot flash studies 0.31899 Hot Flash Related 0.322478 experiencing tamoxifen-induced hot 0.310785 problematic menopausal hot 0.31265 hierba sonajero 0.329084 estrogen replacement therapy 0.321006 Support Care Cancer 0.31053 Cancer Res Treat 0.338604 Cancer Treatment Group 0.35326 after breast 0.314947 Clin Oncol 0.532082 breast cancer 0.920092 health initiative randomized 0.310524 hot flash 0.362781 Pilot evaluation 0.324608 early stage breast 0.318416 Central Cancer Treatment 0.352938 learned from hot 0.311156 Stearns V 0.318536	CLICK HERE
2072	National Cancer Institute	Html	es	Teléfonos celulares y el riesgo de cáncer	Hoja informativa que resume la evidencia disponible acerca del uso de los teléfonos celulares y el riesgo de cáncer.	CERENAT case-control study 0.411745 multicenter case-control study 0.411414 epidemiological study results 0.41093 rayos x 0.411877 brain glucose metabolism 0.429587 case-control study 0.426606 único efecto 0.412309 tumores benignos 0.415961 GSM mobile 0.415087 incidence trends 0.411018 Ningún estudio 0.417181 y el riesgo 0.411067 estudio cerecat 0.417392 nationwide cohort study 0.411491 estudio cefalo 0.417908 NCI evaluó la incidencia 0.412387 Schüz J 0.443349 posibles efectos 0.437506 Estudio Danés 0.41724 Estados Unidos 0.572662 teléfonos análogos 0.439875 teléfonos celulares. Todavía 0.442397 PubMed Abstract 0.994162 ambicioso estudio 0.416033 menor riesgo 0.411527	Danish cohort study 0.411708 mobile phone 0.603266 International Agency 0.410998 cerebral blood flow 0.418576 Johansen C 0.418262 International Journal 0.433338 malignant brain tumours 0.413167 estudio conjunto 0.41602 cohort study 0.416338 Deltour I 0.41865 British Medical Journal 0.421146 brain neoplasms 0.419629 brain tumor risk 0.416486 brain tumours 0.444382 teléfonos celulares y tumores 0.450845 participantes controles 0.41861 international case-control study 0.411613 sistema nervioso central 0.469236 brain tumor 0.443081 cerebro quizás 0.419107 Cancer Institute 0.432735 teléfonos celulares causa 0.474528 pequeños estudios 0.411116 teléfonos celulares análogos 0.479549	CLICK HERE
3581	National Cancer Institute	Html	en	Cancer Screening and Early Detection Research	Information about cancer screening and early detection research, including a summary of NCI programs dedicated to advancing screening and early detection.	new screening test 0.540118 cancer deaths 0.410053 NCI family studies 0.383067 lung cancer 0.420741 Breast Cancer Surveillance 0.38723 regular screening 0.445893 colorectal cancer screening 0.603772 early detection 0.939503 certain cancers 0.363738 nonhereditary cancers 0.350447 cancer diagnosis 0.409297 Early Detection Research 0.39067 Colorectal Cancer Outreach 0.419418 invasive diagnostic tests 0.349791 cervical cancer 0.470854 Reduce Cancer Health 0.403575 follow-up screening 0.454414 population groups 0.405687 cancers 0.545666 effective screening tests 0.700094 cancer screening 0.952427 esophageal cancer 0.349174 cancer prevention 0.403966 cancer screening practices 0.592194 United States 0.470337	screening tests 0.828502 early detection tests 0.394525 Cancer Treatment 0.361701 cancer cells 0.354406 new screening tests 0.532154 successful screening approach 0.50247 annual screening 0.507755 screening clinical trials 0.513432 National Lung Screening 0.514111 breast cancer screening 0.628104 potentially lethal cancers 0.414445 advanced cancer 0.354994 Research Optimizing Screening 0.517143 screen-detected cancers 0.368122 cancer screening tests 0.606127 CT-based screening 0.448353 hereditary cancers 0.34998 lung cancer risk 0.409654 false-positive screening tests 0.535547 Screening Initiative 0.447841 cancer mortality 0.418544 screening methods 0.487692 Cancer Screening Trial 0.590657 life-threatening cancers 0.360993	CLICK HERE
16374	National Cancer Institute	Html	en	Cancer Moonshot℠ – Funding Opportunities	NCI is accepting applications for research grants that support the Cancer Moonshot Blue Ribbon Panel recommendations to accelerate cancer research.	Cancer Drug Resistance 0.295868 Science Network Cancer 0.308038 Human Tumor Atlases 0.404045 Immunotherapy Translational Science 0.984441 Science Accelerating Colorectal 0.287912 Fusion Oncoproteins 0.307628 Cancer Immunoprevention Research 0.286973 Cancer Immunotherapy Translational 0.970237 Network Pediatric Immunotherapy 0.362271 Pediatric Immunotherapy Discovery 0.349074 Tumor Atlases Human 0.296142 Implementation Science Improving 0.29186 Translational Science Network 0.875874 Management Research Research 0.283205 New Enabling Technologies 0.348633 Network Metabolic Reprogramming 0.28898 Immuno-Oncology Translation Network 0.34437 Promote Research Collaborations 0.285621 Science Improving Smoking 0.284218 Colorectal Cancer Screening 0.294277 Research Projects 0.27874 Cancer Data Ecosystem 0.284367 Science Network Metabolic 0.302007 Cancer Moonshot 0.286234 Network Canine Immunotherapy 0.334919	Implementation Science Accelerating 0.293234 PHS2018-1/ Topic 0.305631 Research Centers 0.280481 Network Immuno-Oncology Translation 0.344385 Cancer Immunotherapy Research 0.375931 Symptom Management Research 0.365508 Childhood Cancers 0.296073 Science Network Research 0.294604 Early Detection 0.350699 Accelerating Colorectal Cancer 0.296449 National Cancer Data 0.285248 Science Network Coordinating 0.277495 Network Cancer Immunologic 0.279507 Canine Immunotherapy Trials 0.339278 Network Cancer Immune 0.278836 Translational Studies 0.295595 Human Tumor Atlas 0.288789 Translational Research 0.303812 Cancer Moonshot-related activities 0.277278 Immunotherapy Data Resource 0.338479 Atlases Human Tumor 0.296132 Science Network Pediatric 0.294096 Science Network Immuno-Oncology 0.350197 Implementation Science 0.370631	CLICK HERE